Oculis Holding AG share price logo

Oculis Holding AG

NASDAQ: OCS

Small Cap

$11.93

+0.19

(+1.62%)

Live

as on

Oculis Holding AG Stock Performance

as on June 27, 2026 at 6:06 am IST

  • Day's Low

    Day's High

    $11.70
    $11.95
    downward going graph

    1.93%

    Downside

    0.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $10.52
    $34.48
    downward going graph

    11.82%

    Downside

    188.98%

    Upside

    downward going graph

Oculis Holding AG share price movements today

Previous Close
$11.74
Open
$11.70
Volume
462.5K
Day's Low - High
$11.70 - $11.95
52 Week Low - High
$10.52 - $34.48

Oculis Holding AG Historical Returns

1 Month Return
-60.78 %
3 Month Return
-53.02 %
1 Year Return
-39.73 %
3 Year Return
-5.4 %
5 Year Return
0 %

Oculis Holding AG Stock Fundamentals & Key Indicators

Check Oculis Holding AG market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$698.1M

EPS (TTM)

-1.7681

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-83.2M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

-52.66%

Oculis Holding AG vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oculis Holding AG with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Oculis Holding AG image
Oculis Holding AG
BUY$698.1MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.3B67.15%74.0712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.6B147.08%28.1735.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for Oculis Holding AG Stock including INR - Dollar returns

The Oculis Holding AG stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Oculis Holding AG investment value today

Current value as on today

₹67,496

Returns

-₹32,504

(-32.5%)

Returns from Oculis Holding AG Stock

-₹38,758 (-38.76%)

Dollar Impact

₹6,254 (+6.25%)

Analyst Recommendation on Oculis Holding AG Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Oculis Holding AG. Average target price of $37.36

Oculis Holding AG Share Price Target

Get share price movements and forecasts by analysts on Oculis Holding AG.

What analysts predicted

68.07%UPSIDE

Target Price

$37.36

Current Price

$11.93

Analyzed by

13 Analysts

Target

$37.36

Oculis Holding AG target price $37.36, a slight upside of 68.07% compared to current price of $11.93. According to 13 analysts rating.

Indian Investors' Interest in Oculis Holding AG Stock

Search interest for Oculis Holding AG Stock has increased by 1772% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1772% versus previous 30 day period

Oculis Holding AG Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
-
-
-
0
0
-
-
Gross Profit
-9
-11
-18
-
-
-
-14
0
-
0
Operating Income
-12
-15
-22
-18
-17
-19
-20
-20
-20
-22
EBITDA
-12
-15
-20
-19
-28
-32
-25
-16
-23
-29
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-16
-20
-20
-28
-33
-25
-16
-23
-29
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-14
-18
-23
-23
-32
-37
-25
-16
-23
-29
Net Profit Margin
-6756.22%
-7249.10%
-8505.71%
0.00%
0.00%
0.00%
-9722.22%
-6936.21%
0.00%
0.00%

Oculis Holding AG Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
0
1
0
-
Gross Profit
-9
-9
-22
-32
-57
-
Operating Income
-12
-13
-32
-80
-73
-79
EBITDA
-12
-13
-31
-87
-85
-93
Interest Expense
2
5
6
1
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-14
-18
-38
-88
-85
-94
Income Tax Expense
0
0
0
0
0
0
Net Income
-16
-20
-41
-102
-96
-94
Net Profit Margin
-1497.78%
-1932.50%
-4243.20%
-10056.85%
-12503.94%
0.00%

Oculis Holding AG Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-20
-20
-28
-33
-25
-16
-23
-28
Operating Cash Flow
-13
-13
-10
-10
-18
-17
-13
-15
-15
Investing Cash Flow
-1
-18
4
-1
-51
25
-2
-32
-26
Financing Cash Flow
0
51
0
2
103
0
-1
82
24
Change in Cash
-13
19
-8
-7
32
4
-17
35
-17

Oculis Holding AG Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-38
-88
-85
-94
Operating Cash Flow
-13
-25
-53
-47
-62
Investing Cash Flow
0
-3
-54
-17
-59
Financing Cash Flow
55
1
129
54
178
Change in Cash
41
-26
18
-10
57

Global Institutional Holdings in Oculis Holding AG

Funds
Holdings
Gildi - lifeyrissjodur
4.02%
Alyeska Investment Group, L.P.
0.55%
Pivotal bioVenture Partners Investment Advisor LLC
2.78%
Adage Capital Partners Gp LLC
1.38%
Compagnie Lombard, Odier SCA
0.17%
See all

Insights on Oculis Holding AG

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, OCS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.0% return, outperforming this stock by 58.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, OCS stock has moved down by -60.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 261.0K → 243.0K (in $), with an average decrease of 6.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -16.85M → -29.49M (in $), with an average decrease of 32.4% per quarter

About Oculis Holding AG

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.
OrganisationOculis Holding AG
HeadquartersBahnhofstrasse 20, Zug, Switzerland, 6300
IndustryBiotechnology
CEODr. Riad Sherif M.B.A., M.D.
E-voting on sharesClick here to vote

Key Management of Oculis Holding AG

Name

Title

Ms. Katie Kazem

Chief Legal Officer

Ms. Virginia R. Dean

Chief Human Resources Officer

Dr. Sharon Klier M.D., M.P.H.

Chief Development Officer

Ms. Gudrun Bachmann Ph.D.

Chief Technology Officer

Ms. Sylvia Cheung

Chief Financial Officer

Dr. Ramin Tadayoni M.D., Ph.D.

Chief Scientific Officer

Mr. Páll Ragnar Jóhannesson

Chief Business Officer

Ms. Rebecca Weil Ph.D.

Chief Commercial Officer

Dr. Snehal Shah Pharm.D.

President of Research & Development

Dr. Riad Sherif M.B.A., M.D.

CEO & Director

FAQs

What is Oculis Holding AG share price today?

Oculis Holding AG share price today is $11.93 as on . Oculis Holding AG share today touched a day high of $11.95 and a low of $11.7.

What is the 52 week high and 52 week low for Oculis Holding AG share?

Oculis Holding AG share touched a 52 week high of $34.48 on and a 52 week low of $10.52 on . Oculis Holding AG stock price today i.e. is trending at $11.93,which is 65.40% down from its 52 week high and 13.40% up from its 52 week low.

What is Oculis Holding AG's market capitalisation today?

Oculis Holding AG market capitalisation is $0.00T as on .

How to invest in Oculis Holding AG Stock (OCS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oculis Holding AG on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oculis Holding AG Shares that will get you 0.1257 shares as per Oculis Holding AG share price of $11.93 per share as on June 27, 2026 at 12:36 am IST.

What is the minimum amount required to buy Oculis Holding AG Stock (OCS) from India?

Indian investors can start investing in Oculis Holding AG (OCS) shares with as little as ₹94.385 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.85 in Oculis Holding AG stock (as per the Rupee-Dollar exchange rate as on ). Based on Oculis Holding AG share’s latest price of $11.93 as on June 27, 2026 at 12:36 am IST, you will get 0.8382 shares of Oculis Holding AG. Learn more about fractional shares .